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Use of external iliac artery in renal
revascularization surgery: Long-term angiographic
assessment
A. Dinis da Gama, MD, PhD, Carlos S. Sarmento, MD, Germano X. do Carmo, MD, and
Frederico S. Machado, MD, Lisbon, Portugal
Purpose: The external iliac artery has physical characteristics, in particular, caliber and length, similar to those of the renal
artery and would thus seem to be an ideal substitute for it. However, there are no studies in the literature designed to
confirm this possibility. The present study was designed to demonstrate the feasibility of use of the external iliac artery
as a substitute for the renal artery in surgical revascularization of renal artery fibrodysplasia and to assess the long-term
biologic behavior of the external iliac artery so used.
Methods: Twelve patients (11 female, 1 male), ages 1 to 43 years (mean, 24.4 years), with severe hypertension underwent
aortorenal bypass grafting with use of the external iliac artery to treat preocclusive stenotic lesions (n  7), complete
occlusion (n 3), or aneurysm (n 2) of the renal artery. It was considered unnecessary to reestablish circulation in the
donor limb in 2 patients (young children), and transposition of the ipsilateral internal iliac artery was performed in 9
patients; in the remaining patient circulation was reestablished with insertion of an iliofemoral prosthesis.
Results: There were no operative deaths. In 1 patient nephrectomy was necessary because of occlusion of the graft as a
consequence of technical complications. In 8 patients there was immediate normalization of blood pressure without aid
of medication, and in the remaining 3 patients an antihypertensive drug was prescribed.
Two patients were lost to follow-up; the other 9 were assessed with angiography at a mean of 8.8 years after the operation.
All grafts were found to be in excellent condition, with no evidence of dilatation, kinking, twisting, anastomotic
fibroplasia, or wall irregularities.
Conclusion: On the basis of this experience, the external iliac artery is confirmed as a substitute for the renal artery, and
the excellent long-term results would seem to make it particularly useful in young patients with long life expectancy, such
as those with renal artery fibrodysplasia. (J Vasc Surg 2003;38:123-8.)
Autologous arteries are the best substitute for use in
renal revascularization surgery, because of their excellent
biologic behavior and durability.
The main limitation to their use is their relative scarcity.
There are few arteries in the body with similar diameter and
length as the renal artery that can be used without causing
ischemia in the organs or anatomic areas that depend on
them. As a result, only the internal iliac artery,1-5,7 splenic
artery,8-10 hepatic artery,11-13 and less often the gastrodu-
odenal artery14,15 have been used as autologous grafts in
renal revascularization surgery.
The external iliac artery has physical characteristics, ie,
caliber and length, similar to those of the renal artery and
would thus seem to be an excellent substitute for it. Al-
though there are a few references to this in the literature,
there have so far been no studies designed to demonstrate
the feasibility of its use or to assess its biologic behavior.
The present study was designed to assess the mid-term
and long-term behavior of the external iliac artery when
used as a substitute for the renal artery in reconstructive
surgery and evaluated with angiography.
MATERIAL AND METHODS
From October 1989 to May 1996, 12 patients (11
female, 1 male), ages 1 to 43 years (mean, 24.4 years),
underwent revascularization surgery because of renal artery
fibrodysplasia as revealed at angiography (Table). All pa-
tients had hypertension of varying severity and duration
that was resistant to control with pharmacologic means
including a wide range of antihypertensive agents. In a
1-year-old baby, hypertension resulted in episodes of con-
vulsive encephalopathy.
The disease was unilateral in all patients. Seven patients
had preocclusive lesions suggestive of intimal fibroplasia; 3
patients had complete occlusion of the renal artery, but
with evidence of functioning kidney; and the remaining 2
patients had renal artery aneurysms. Patients with bilateral
lesions or with branch involvement were excluded from the
study. Complete angiographic assessment was made at
renal angiography, to rule out dysplastic disease in iliac
vessels. No evidence of compromised renal function was
found in any patient.
At midline laparotomy, the retroperitoneal space was
approached via incision of the colonic gutter, followed by
exposure of the renal artery and vein and then the common,
external, and internal iliac arteries on that side. A section of
appropriate length was dissected from the external iliac
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artery and preserved in saline solution at 4° C until implan-
tation.
Arterial continuity in the donor limb was not reestab-
lished in 2 young patients (ages 1 and 8 years), because it
was considered that in patients in this age group there is
potential for development of a highly efficient collateral
circulation, which subsequently proved to be the case. In 9
patients transposition of the ipsilateral internal iliac artery
was performed. After ligation of its collateral vessels and
distal transection, the artery was anastomosed to the distal
end of the external iliac artery, reestablishing circulatory
continuity of the limb. In the remaining patient, a 43-year-
old woman, it was necessary to insert an iliofemoral pros-
thesis as a last resort, because of poor condition of the
internal iliac artery (Fig 1).
Renal revascularization was carried out with insertion
of the removed segment of the external iliac artery, with
end-to-side anastomosis to the aorta and end-to-end anas-
tomosis to the receiving renal artery.
All patients underwent angiography before hospital
discharge, to assess the condition and quality of the revas-
cularization procedure. Periodic follow-up included clinical
examination and laboratory studies. After the sixth year
after the operation, another angiogram was obtained and
compared with the angiogram obtained at hospital dis-
charge.
RESULTS
There was no mortality or significant morbidity, except
in 1 patient with a renal artery aneurysm. In this patient the
graft became occluded as a result of technical failure, lead-
ing to infarction of the kidney, necessitating nephrectomy.
In 8 patients there was immediate normalization of
blood pressure, with no need for any pharmacologic treat-
Number Sex
Age
(y) Lesion Operation LL revasc Clinical outcome
Follow-up
(y) Angiography
1 M 8 Occlusion RR 10/89 — Excellent 12 Normal
2* F 1 Pre-occl. stenosis RR 12/89 — Excellent — —
3 F 13 Pre-occl. stenosis RR 04/92 Hypogastric transposition Excellent 10 Normal
4 F 39 Pre-occl. stenosis RR 07/92 Hypogastric transposition Good 10 Normal
5 F 32 Pre-occl. stenosis RR 01/93 Hypogastric transposition Good 9 Normal
6 F 43 Pre-occl. stenosis RR 01/93 Iliofemoral prosthesis Good 9 Normal
7 F 41 Occlusion LR 08/93 Hypogastric transposition Excellent 8 Normal
8* F 34 Pre-occl. stenosis RR 12/93 Hypogastric transposition Excellent — —
9 F 17 Aneur. LR 08/94 Hypogastric transposition Excellent 7 Normal
10 F 25 Pre-occl. stenosis RR 10/95 Hypogastric transposition Excellent 6 Normal
11 F 16 Aneur. LR 02/96 Hypogastric transposition Occlusion,
nephrectomy
— —
12 F 26 Occlusion RR 05/96 Hypogastric transposition Excellent 6 Normal
*Lost for follow-up.
Fig 1. Revascularization of donor lower limb with native collateral network (a), transposition of hypogastric artery
(b), and iliofemoral prosthesis (c).
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ment; in the remaining 3 patients an antihypertensive drug
was required to normalize blood pressure.
Reconstruction of the external iliac artery succeeded
well in every patient. Two children without reconstruction
showed no clinical consequences in the postoperative pe-
riod. One baby, 1 year old, was lost to follow-up; and the
second patient, an 8-year-old boy, complained of mild
claudication, which gradually resolved, becoming com-
pletely aymptomatic.
Duration of follow-up was 1 to 12 years (mean, 8.8
years), and clinical results remained unchanged during this
period. Two patients with excellent initial clinical results
were lost to follow-up. In 6 patients blood pressure re-
mained normal with no medication; in the other 3 patients
blood pressure control was maintained with adjuvant med-
ication, with a single drug.
After the sixth year after the operation, patients under-
went conventional angiography, according to agreement,
consent, and availability of each patient. Comparison with
the angiogram obtained at hospital discharge showed that
in all patients there was anatomic integrity of the graft, with
no evidence of dilatation, stenosis, kinking, or wall irregu-
larities (Fig 2).
During follow-up, status of the revascularized donor
limb was assessed angiographically, and either the hypogas-
tric transposition or the prosthetic graft interposition was
patent in every case. No anatomic or functional conse-
quences were observed after these procedures. Contralat-
eral renal artery stenosis, commonly observed in very young
patients, was not noted in this series, which included only 2
children.
Only 1 patient, a woman aged 51 years at assessment,
demonstrated evidence of moderate progression of aortic
disease, which had not reached the origin of the graft.
DISCUSSION
The success of surgical treatment of renovascular hy-
pertension, when evaluated over the long term, depends
mainly on the therapeutic method used.
In addition to the immediate complications noted with
various methods, both endovascular and direct reconstruc-
tive surgery are associated with late complications inherent
to the procedures that tend to compromise results in the
long term. This takes on particular importance in young
patients with long life expectancy, eg, those with renal
artery fibrodysplasia. In these patients it is necessary to
choose not only the most effective of the various renal
revascularization procedures but also that with the longest
lasting results.
In certain forms of fibrodysplasia, primarily those in-
volving the tunica media of the arterial wall, excellent
results are attained with endoluminal techniques.16-20
However, other forms of the disease, eg, fibroplasia of the
intima, are resistant to endoluminal intervention, with high
rates of technical failure or recurrence of lesions.21-24
It is, nevertheless, important to note that many of the
studies published report only results obtained immediately
after the procedure, and few report long-term results. Effi-
cacy and durability are generally assessed indirectly with
clinical (blood pressure) or laboratory (renal function) val-
ues, ignoring an essential aspect, ie, morphologic evalua-
tion of the integrity of the procedure, which can only be
confirmed with imaging methods, in particular, angiogra-
phy.
Indeed, no studies in the specialist literature are based
on angiographic documentation of the mid-term and long-
term efficacy and durability of endoluminal procedures.
This is particularly important given that there are powerful
biologic arguments that suggest these procedures are likely
to fail, eg, myoproliferative response of the arterial wall to
the injury caused by dilatation, and reaction to a foreign
body triggered by presence of the stent.16,17,25,26
Prosthetic substitutes are rarely used in isolated renal
artery revascularization,27,28 although they are more fre-
quently used when the abdominal aorta must be replaced at
the same time because of concomitant obstruction or an-
eurysm.29,30 Prostheses of a caliber compatible with the
renal artery are usually small in diameter, and they have low
permeability indexes in different vascular territories, for
reasons related to their thrombogenicity and biologic be-
havior. Moreover, prostheses are vulnerable to infection
and development of anastomotic aneurysm, and in the long
term, tissue degradation is likely.31
Historically, autologous veins have been the preferred
substitute in renal revascularization surgery. Their availabil-
ity and suitable biologic behavior facilitate and encourage
their large-scale use.31-35 However, it is known from exten-
sive experience that vein grafts undergo degenerative alter-
ations and progressive structural degradation some years
after implantation, leading to various complications.36,37
This has discouraged use of autologous veins as a first-line
substitute in myocardial revascularization surgery, and has
led to use of the internal mammary artery or other autolo-
gous arteries, eg, the gastroepiploic and radial arteries.38-40
Little information exists in the literature regarding
structural alterations of renal vein grafts, probably because
there is little material available for study. However, there is
no evidence to suggest they would perform differently from
vein grafts in other positions, eg, coronary or femoropop-
liteal vein grafts.
In a classic work published in 1973, Stanley et al41
assessed 100 aortorenal venous grafts with angiography and
found significant dilatation in 45% of the grafts, especially
in younger patients. Approximately 8% of dilatations
evolved into aneurysms, mainly in patients younger than 18
years. The results of this study were corroborated by Dean
et al,42 who showed that 20% of venous grafts demon-
strated diffuse dilatation, 5% of which evolved into true
aneurysms.
Therefore, while autologous veins are still widely con-
sidered the graft of choice for renal revascularization, they
should be used with caution in young patients, because of
the possibility of late degeneration, aneurysm formation, or
even rupture.43,44 Inasmuch as renal artery fibrodysplasia is
a disease that affects young age groups, use of autologous
venous substitutes is compromised in part by the possibility
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 1 da Gama et al 125
of such complications, and this has encouraged use of
autologous arterial substitutes.
Wylie et al1,2 were pioneers in the use of arterial au-
tografts in renal revascularization surgery, particularly the
internal iliac artery, highlighting its qualities and satisfac-
tory results. This opinion was subsequently confirmed by
many other authors and researchers, who emphasized that
the internal iliac artery is an excellent substitute for the renal
artery, particularly when there are concomitant lesions in
peripheral branches.3-7 However, it should be remembered
that the anatomy of the internal iliac artery is not always
favorable; its main stem may be short, and its caliber may be
unsuitable if it divides early into various collateral vessels,
which may mean it cannot be used. Moreover, the internal
iliac artery is sometimes affected by fibrotic parietal lesions
in women who have borne children, as we found, probably
as a consequence of hemodynamic stress caused by preg-
nancy; this is another factor that may limit its use.
The arteries of the digestive apparatus, branches of the
celiac trunk, eg, splenic, hepatic, and gastroduodenal arter-
Fig 2. A, Postoperative angiogram. B, Angiogram obtained at 6-year follow-up (same patient as in A). C,
Postoperative angiogram. D, Angiogram obtained at 10- year follow-up (same patient as in C).
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ies, have been the basis of highly successful experiences in
renal revascularization, heralding the advent of “extra-
anatomic revascularization.”8-15 Use of these arteries is
particularly indicated in severe aortic disease, which pre-
cludes implantation of an aortorenal bypass graft. How-
ever, in terms of caliber, length, and output, these arteries
do not always fulfil the essential requirements for the pro-
cedure, and sometimes lead to problems of technical feasi-
bility or low inflow, which may compromise revasculariza-
tion.
The external iliac artery is, in terms of caliber and
length, similar to the renal artery, and it has the additional
advantages of not having collateral vessels and of being
easily accessible within the same operative field. Although
there is mention in the literature of occasional use of the
external iliac artery by Wylie et al,2 to date no study has
been designed to assess its efficacy and biologic behavior,
which provided incentive for the present work. The main
limitation to use of the external iliac artery is compromised
vascularization of the donor limb. This seems to have no
immediate consequences in infants or young children, in
whom there is potential for development of highly efficient
collateral circuits, as our experience showed and as has been
pointed out in treatment of traumatic lesions in this age
group.45
In other cases, the option to transpose the ipsilateral
internal iliac artery proved easy to perform and effective,
even when the internal iliac artery was of poor quality. In 1
patient, however, it was necessary to use a polytetrafluoro-
ethylene iliofemoral prosthesis to reestablish arterial conti-
nuity in the donor limb.
Results obtained with use of the external iliac artery,
both clinically and anatomically over the long term, were
considered excellent. During mean follow-up of 8.8 years,
6 patients maintained normal blood pressure without treat-
ment, and the other 3 patients, the oldest in the series,
required only one drug to control blood pressure effec-
tively. The follow-up angiogram was compared with the
angiogram obtained at hospital discharge, and showed
complete integrity of the grafts, with no evidence of alter-
ations or complications, either anatomic or functional.
The external iliac artery thus is another alternative
substitute for the renal artery. The excellent results ob-
tained over the long term seem to make its use particularly
indicated in young patients with long life expectancy, eg,
those with renal artery fibrodysplasia.
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